5 reviews submitted with a 8. 16 feb 2016 february 16, 2016 by alex keown, biospace. 16 feb 2016 merck (mrk) has received a complete response letter for its supplemental new drug applications for zetia and vytorin from the fda. 16 feb 2016 the company has applied on the basis of the clinical database of improve-it ( improved reduction of outcomes: vytorin efficacy international; 10 jan 2014 1 answer - posted in: vytorin, erectile dysfunction, dosage - answer: yes, vytorin can cause erectile dysfunction. 16 feb 2016 the fda has turned down merck;s application to expand the indication for its cholesterol-lowering drug ezetimibe (zetia and vytorin, merck). 16 feb 2016 the us food and drug administration (fda) has refused to approve zetia and vytorin, merck;s medicines that are used to reduce the risk of; 28 feb 2013 vytorin (ezetimibe/simvastatin) is a lipid-lowering product that selectively vytorin contains ezetimibe and simvastatin, two lipid-lowering. 16 jan 2008 you;ve heard the commercial: ;cholesterol comes from two sources. 16 oct 2013 quantitative and qualitative pleiotropic differences between simvastatin single and vytorin combination therapy in hypercholesterolemic; 8 jan 2009 the fda has just released their review of the enhance trial involving vytorin. 17 feb 2016 fda declined to approve merck;s claim that its cholesterol-lowering drugs zetia and vytorin reduce the risk of heart attacks and strokes in; vytorin. 17 nov 2014 after years of anticipation, merck has released top-line results of a study of its vytorin cholesterol drug ; which combines the zetia and zocor; 14 dec 2015 (adds comment from merck). 17 nov 2014 file - this 2004 file photo provided by schering-plough corp.